Glomeria Therapeutics

📍 Chieti Scalo, Italy🗓 Founded 2010👥 4 employees💰 Last funded Nov 2014
Glomeria Therapeutics is a company specialized in research and development. Our mission is to deliver hospital products, drugs and medical therapy devices to patients with severe forms of nephropathy and cardiopathy. It is Glomeria Therapeutics’ policy to keep infrastructure costs to a minimum whilst maximizing access to scientific knowledge and research in the biomedical field. Therefore, all the creative and development phases that go into identifying new therapy targets (pre-clinical pharmacology, applied engineering, prototype building, etc) are conducted in-house, while the industrial development is farmed out to service firms specialized in the target sectors. The management of Glomeria Therapeutics draws on a group of professionals with high qualification in research and development for pharmaceutical products and medical devices. As a whole the company management and scientific board can count on a solid experience in all branches of the pharmaceutics and medical apparatus.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2010
Founded
Investor geography1 country
Italy
1
Frequently asked questions
Who invested in Glomeria Therapeutics?
Glomeria Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did Glomeria Therapeutics last raise funding?
The most recent investment in Glomeria Therapeutics recorded on gritt.io was in November 2014.
When was Glomeria Therapeutics founded?
Glomeria Therapeutics was founded in 2010.
What industry is Glomeria Therapeutics in?
Glomeria Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Glomeria Therapeutics based?
Glomeria Therapeutics is headquartered in Chieti Scalo, Italy.